It’s common for people with relapsing-remitting multiple sclerosis (RRMS) to switch to a different disease modifying therapy (DMT) over the course of their treatment. For this reason, it benefits you to learn about the RRMS treatments on the market today. With about 20 disease-modifying therapies now approved by the U.S. Food and Drug Administration (FDA) to treat relapsing-remitting multiple sclerosis, it can be difficult to keep track of all the treatment options available.
This quiz is designed to test your knowledge of relapsing-remitting MS treatments and help you decide whether it’s time to talk to your doctor about treatment options.
0 to 3 points
The good news is, you may have treatment options you didn’t know about! You have more to learn about RRMS treatments, and your doctor can help you figure out the best treatment options for you.
4 to 6 points
You have a good working knowledge of RRMS treatments, but there is more to learn! You may benefit from talking to your doctor about treatment options to make sure you understand all of your choices and which may be best for you.
7 points
You are very knowledgeable about RRMS treatments! You are in a great position to talk to your doctor about your individual benefits and risks with each treatment option.
For help with that conversation, check out Making RRMS Treatment Decisions: A Doctor Discussion Guide.
On MyMSTeam, the social network for people with multiple sclerosis and their loved ones, more than 170,000 members come together to ask questions, give advice, and share their stories with those who understand life with MS.
Did the quiz tell you anything you didn’t know about disease-modifying therapies for MS? Share in the comments below, or start a conversation with others on MyMSTeam.
Get updates directly to your inbox.
Become a member to get even more:
A MyMSTeam Member
According to the quiz I know virtually nothing and I agree with that. I have a whole bunch to learn. The information provided has been very helpful.
We'd love to hear from you! Please share your name and email to post and read comments.
You'll also get the latest articles directly to your inbox.